Valuation: Nexentis Technologies Inc.

Market Cap 2.78M 2.43M 2.25M 2.08M 3.94M 266M 4.01M 26.89M 10.54M 130M 10.45M 10.22M 452M P/E 2024
-0.28x
P/E 2025 -0.34x
Enterprise Value -296K -259K -239K -221K -419K -28.25M -426K -2.86M -1.12M -13.87M -1.11M -1.09M -48.05M EV / Sales 2024
1.64x
EV / Sales 2025 -
Free-Float
77.36%
Yield 2024 *
-
Yield 2025 -
1 day+2.14%
1 week-11.40%
Current month-11.60%
1 month-24.25%
3 months-18.06%
6 months-67.89%
Current year-67.60%
1 week 3.31
Extreme 3.31
4.19
1 month 3.31
Extreme 3.31
23.8
Current year 3.31
Extreme 3.31
23.8
1 year 3.31
Extreme 3.31
89.79
3 years 3.31
Extreme 3.31
4,047.41
5 years 3.31
Extreme 3.31
17,921.78
10 years 3.31
Extreme 3.31
54,022.91
Manager TitleAgeSince
Chief Executive Officer 60 2020-11-04
Director of Finance/CFO 39 2022-04-17
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 60 2021-01-11
Chairman 62 2021-05-23
Director/Board Member 47 2021-05-17
Date Insider Type Main position Quantity % Market Cap.
02-08Free

Chairman

116,286 4.3350%
02-08Free

Controller

50,000 1.8639%
02-08Free

Chief Financial Officer

50,000 1.8639%
Change 5-day change 1-year change 3-year change Capi.($)
+2.14%-11.40%-93.57%-99.62% 2.72M
-1.55%-2.26%+10.05%+46.35% 56.97B
+0.11%-.--%-.--%-.--% 12.96B
-1.50%+7.29%+46.92%+196.32% 11.28B
-4.21%-11.85%+23.98%+63.49% 7.77B
-4.34%-3.58%-32.92%-15.21% 6.54B
+0.49%-3.08%-9.09%+81.20% 5.72B
+2.16%-1.97%-10.11%-9.95% 5.13B
-0.18%+5.00%+20.25%+35.16% 4.7B
+0.68%-1.10%-35.23%-28.84% 4.07B
Average -0.62%-2.22%-7.97%+26.89% 11.51B
Weighted average by Cap. -1.29%-1.46%+7.99%+49.59%

Financials

2024 2025
Net sales 210K 184K 169K 157K 298K 20.04M 302K 2.03M 795K 9.84M 788K 771K 34.1M -
Net income -5.19M -4.54M -4.19M -3.88M -7.36M -496M -7.48M -50.17M -19.67M -243M -19.5M -19.07M -843M -4M -3.5M -3.23M -2.99M -5.67M -382M -5.77M -38.68M -15.16M -188M -15.03M -14.71M -650M
Net Debt -2.48M -2.17M -2M -1.85M -3.52M -237M -3.58M -24.01M -9.41M -116M -9.33M -9.13M -403M -3.08M -2.69M -2.48M -2.3M -4.36M -294M -4.43M -29.75M -11.66M -144M -11.56M -11.31M -500M
Logo Nexentis Technologies Inc.
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.
Employees
8
Date Price Change Volume
26-07-09 US$3.810 +2.14% 33,840
26-07-08 US$3.730 -3.62% 44,561
26-07-07 US$3.870 +1.57% 317,968
26-07-06 US$3.810 -11.40% 107,227
26-07-02 US$4.300 -3.59% 123,008
  1. Stock Market
  2. Stocks
  3. NXTS Stock